Pharmaceutical Analysis & Statistics, July 2014 (p100)

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

2971-3010 of about 28 000 reports

Purchase Reports From Reputable Market Research Publishers

IL-1 Receptor Antagonists -Pipeline Insights, 2014

IL-1 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-1 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-13 Receptor Antagonists -Pipeline Insights, 2014

IL-13 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-13 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-17 Receptor Antagonists -Pipeline Insights, 2014

IL-17 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-17 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-8 Receptor Antagonists -Pipeline Insights, 2014

IL-8 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-8 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-23 Receptor Antagonists -Pipeline Insights, 2014

IL-23 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-23 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-4 Receptor Antagonists -Pipeline Insights, 2014

IL-4 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-4 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-6 Receptor Antagonists -Pipeline Insights, 2014

IL-6 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-6 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors -Pipeline Insights, 2014

Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Inhibitors of Apoptosis (IAP) Antagonists -Pipeline Insights, 2014

Inhibitors of Apoptosis (IAP) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inhibitors of Apoptosis (IAP) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Inosine 5%-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors -Pipeline Insights, 2014

Inosine 5%-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inosine 5'-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development
Inositol 5%-Phosphatase (SHIP) Agonists -Pipeline Insights, 2014

Inositol 5%-Phosphatase (SHIP) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inositol 5'-Phosphatase (SHIP) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Vitamin and Supplement
Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors -Pipeline Insights, 2014

Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Integrin Alpha4beta1/Very Late Antigen-4 (VLA-4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

Interferon Gamma Receptor (IFNGR) Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Gamma Receptor (IFNGR) Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug and Medication
Interferon Receptor Binders -Pipeline Insights, 2014

Interferon Receptor Binders -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interferon Receptor Binders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug and Medication
Interleukin-1 (IL-1) Inhibitors -Pipeline Insights, 2014

Interleukin-1 (IL-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-1 (IL-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-10 (IL-10) Receptor Agonists -Pipeline Insights, 2014

Interleukin-10 (IL-10) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-10 (IL-10) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-11 (IL-11) Receptor Agonists -Pipeline Insights, 2014

Interleukin-11 (IL-11) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-11 (IL-11) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-2 (IL-2) Inhibitors -Pipeline Insights, 2014

Interleukin-2 (IL-2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-2 (IL-2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014

Interleukin-2 (IL-2) Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-2 (IL-2) Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-13 (IL-13) Inhibitors -Pipeline Insights, 2014

Interleukin-13 (IL-13) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-13 (IL-13) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-5 (IL-5) Inhibitors -Pipeline Insights, 2014

Interleukin-5 (IL-5) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-5 (IL-5) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2014

Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-16 (IL-16) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2014

Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-17 (IL-17) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-8 (IL-8) Inhibitors -Pipeline Insights, 2014

Interleukin-8 (IL-8) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-8 (IL-8) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-23 (IL-23) Inhibitors -Pipeline Insights, 2014

Interleukin-23 (IL-23) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-23 (IL-23) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-4 (IL-4) Inhibitors -Pipeline Insights, 2014

Interleukin-4 (IL-4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-4 (IL-4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Ionotropic Glutamate Receptor Antagonists -Pipeline Insights, 2014

Ionotropic Glutamate Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ionotropic Glutamate Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Janus Kinase (JAK) Inhibitors -Pipeline Insights, 2014

Janus Kinase (JAK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase (JAK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights, 2014

Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase (JNK) Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Kainate Receptor Antagonists -Pipeline Insights, 2014

Kainate Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Kainate Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
About 55 000 reports

Download Unlimited Documents from Trusted Public Sources

Tobacco Industry in the US

  • Mimicking Airlines, Hotels get Fee-happy
  • August 2014
  • Drug And Medica...  

    Smoking Treatme...  

    E-cigarette  

  • United States  

View report >

Drug Demand In Europe

August 2014

About 600 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.